Articles |
From the Cardiovascular Research Center & Cardiac Unit (R.J.H., U.S., T.M., A.R.), Medical Services, and the Department of Preventive Medicine (J.X.K.), Massachusetts General Hospital, Harvard Medical School, Charlestown.
Correspondence to Anthony Rosenzweig, MD, Cardiovascular Research Center, Massachusetts General Hospital-East, 149 13th Street, 4th Floor, Room 4207, Charlestown, MA 02129.
Abstract Phospholamban forms an integral part of the cardiac sarcoplasmic reticulum (SR) and regulates the activity of SR Ca2+-ATPase (SERCA2a). A number of studies have suggested a decrease in SERCA2a relative to phospholamban in heart failure. To test the hypothesis that changes in the relative abundance of phospholamban to SERCA2a could account for the pathophysiological abnormalities in Ca2+ handling observed in failing myocardium, we created a recombinant adenovirus designed to overexpress phospholamban (Ad.RSV.PL). In neonatal rat cardiomyocytes, Ad.RSV.PL increased the expression of phospholamban in a concentration-dependent fashion, reaching 280±43% at a multiplicity of infection (MOI) of 10.0 plaque forming units (pfu)/cell at 48 hours. The relationship between Ca2+-ATPase activity and [Ca2+] was shifted rightward in membrane preparations from cardiomyocytes infected with Ad.RSV.PL. Intracellular Ca2+ transients measured in the neonatal cells infected with Ad.RSV.PL (MOI, 10 pfu/cell) were characterized by (1) a significant prolongation of the relaxation phase (344±26 versus 710±56 milliseconds, P<.01), (2) a decrease in peak [Ca2+]i (967±43 versus 630±33 nmol/L, P<.01), and (3) an elevation in resting [Ca2+]i (143±14 versus 213±17 nmol/L, P<.05). Similarly, the time course of shortening was prolonged in myocytes infected with Ad.RSV.PL. These effects were partially restored by simultaneous transduction with an adeno-virus carrying SERCA2a. Cardiomyocytes infected with Ad.RSV.PL had an abnormal frequency response: a decrease in peak [Ca2+]i and an increase in resting [Ca2+]i with increasing frequency. These findings indicate that adenovirus-mediated gene transfer of phospholamban modifies intracellular Ca2+ handling and the frequency response in cardiomyocytes. Our results suggest that alterations in the ratio of phospholamban to SERCA2a could account for the abnormalities in Ca2+ handling observed in heart failure and that overexpression of SERCA2a can largely correct these abnormalities.
Key Words: gene transfer sarcoplasmic reticulum phospholamban Ca2+ Ca2+-ATPase
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamamoto, M. Yano, X. Xu, H. Uchinoumi, H. Tateishi, M. Mochizuki, T. Oda, S. Kobayashi, N. Ikemoto, and M. Matsuzaki Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts Circulation, February 12, 2008; 117(6): 762 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Armoundas, J. Rose, R. Aggarwal, B. D. Stuyvers, B. O'Rourke, D. A. Kass, E. Marban, S. R. Shorofsky, G. F. Tomaselli, and C. William Balke Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1607 - H1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hiranandani, T. Bupha-Intr, and P. M. L. Janssen SERCA overexpression reduces hydroxyl radical injury in murine myocardium Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3130 - H3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Maier, C. Wahl-Schott, W. Horn, S. Weichert, C. Pagel, S. Wagner, N. Dybkova, O. J. Muller, M. Nabauer, W.-M. Franz, et al. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats Cardiovasc Res, September 1, 2005; 67(4): 636 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oda, M. Yano, T. Yamamoto, T. Tokuhisa, S. Okuda, M. Doi, T. Ohkusa, Y. Ikeda, S. Kobayashi, N. Ikemoto, et al. Defective Regulation of Interdomain Interactions Within the Ryanodine Receptor Plays a Key Role in the Pathogenesis of Heart Failure Circulation, June 28, 2005; 111(25): 3400 - 3410. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt, X. Zhu, D. Lebeche, F. Huq, J. L. Guerrero, and R. J. Hajjar In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts Cardiovasc Res, May 1, 2005; 66(2): 318 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kedar, H. McDonough, R. Arya, H.-H. Li, H. A. Rockman, and C. Patterson Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I PNAS, December 28, 2004; 101(52): 18135 - 18140. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Fan, G. Chu, B. Mitton, Q. Song, Q. Yuan, and E. G. Kranias Small Heat-Shock Protein Hsp20 Phosphorylation Inhibits {beta}-Agonist-Induced Cardiac Apoptosis Circ. Res., June 11, 2004; 94(11): 1474 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Champion, D. Georgakopoulos, E. Takimoto, T. Isoda, Y. Wang, and D. A. Kass Modulation of In Vivo Cardiac Function by Myocyte-Specific Nitric Oxide Synthase-3 Circ. Res., March 19, 2004; 94(5): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huke, L. H Liu, D. Biniakiewicz, W. T Abraham, and M. Periasamy Altered force-frequency response in non-failing hearts with decreased SERCA pump-level Cardiovasc Res, September 1, 2003; 59(3): 668 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. ISODA, N. PAOLOCCI, K. HAGHIGHI, C. WANG, Y. WANG, D. GEORGAKOPOULOS, G. SERVILLO, M. A. DELLA FAZIA, E. G. KRANIAS, A. A. DEPAOLI-ROACH, et al. Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator) FASEB J, February 1, 2003; 17(2): 144 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. del Monte and R. J Hajjar Targeting calcium cycling proteins in heart failure through gene transfer J. Physiol., January 1, 2003; 546(1): 49 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Asahi, K. Kurzydlowski, M. Tada, and D. H. MacLennan Sarcolipin Inhibits Polymerization of Phospholamban to Induce Superinhibition of Sarco(endo)plasmic Reticulum Ca2+-ATPases (SERCAs) J. Biol. Chem., July 19, 2002; 277(30): 26725 - 26728. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Carr, A. G. Schmidt, Y. Suzuki, F. del Monte, Y. Sato, C. Lanner, K. Breeden, S.-L. Jing, P. B. Allen, P. Greengard, et al. Type 1 Phosphatase, a Negative Regulator of Cardiac Function Mol. Cell. Biol., June 15, 2002; 22(12): 4124 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aikawa, G. S. Huggins, and R. O. Snyder Cardiomyocyte-specific Gene Expression Following Recombinant Adeno-associated Viral Vector Transduction J. Biol. Chem., May 17, 2002; 277(21): 18979 - 18985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Del Monte, K. Butler, W. Boecker, J. K. Gwathmey, and R. J. Hajjar Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure Physiol Genomics, April 10, 2002; 9(1): 49 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Periasamy Adenoviral-Mediated SERCA Gene Transfer Into Cardiac Myocytes : How Much Is Too Much? Circ. Res., March 2, 2001; 88(4): 373 - 375. [Full Text] [PDF] |
||||
![]() |
N. Chossat, F. Griscelli, P. Jourdon, D. Logeart, T. Ragot, M. Heimburger, M. Perricaudet, A.-M. Lompre, S. Hatem, and J.-J. Mercadier Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling Cardiovasc Res, February 1, 2001; 49(2): 288 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lehnart, P. M. L. Janssen, W. M. Franz, J. K. Donahue, J. H. Lawrence, E. Marban, J. Prestle, and G. Hasenfuss Preservation of myocardial function after adenoviral gene transfer in isolated myocardium Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H986 - H991. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eizema, H. Fechner, K. Bezstarosti, S. Schneider-Rasp, A. van der Laarse, H. Wang, H.-P. Schultheiss, W. C. Poller, and J. M. J. Lamers Adenovirus-Based Phospholamban Antisense Expression as a Novel Approach to Improve Cardiac Contractile Dysfunction : Comparison of a Constitutive Viral Versus an Endothelin-1-Responsive Cardiac Promoter Circulation, May 9, 2000; 101(18): 2193 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Brittsan, A. N. Carr, A. G. Schmidt, and E. G. Kranias Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban J. Biol. Chem., April 14, 2000; 275(16): 12129 - 12135. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hajjar, F. del Monte, T. Matsui, and A. Rosenzweig Prospects for Gene Therapy for Heart Failure Circ. Res., March 31, 2000; 86(6): 616 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S Maier, C. Schwan, W. Schillinger, K. Minami, U. Schutt, and B. Pieske Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium Cardiovasc Res, March 1, 2000; 45(4): 913 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt, F. del Monte, M. I. Miyamoto, T. Matsui, J. K. Gwathmey, A. Rosenzweig, and R. J. Hajjar Restoration of Diastolic Function in Senescent Rat Hearts Through Adenoviral Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase Circulation, February 22, 2000; 101(7): 790 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Walker, F. A. Crawford Jr, and F. G. Spinale MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400. [Full Text] [PDF] |
||||
![]() |
M. I. Miyamoto, F. del Monte, U. Schmidt, T. S. DiSalvo, Z. B. Kang, T. Matsui, J. L. Guerrero, J. K. Gwathmey, A. Rosenzweig, and R. J. Hajjar Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure PNAS, January 18, 2000; 97(2): 793 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Ravens and D Dobrev Regulation of sarcoplasmic reticulum Ca2+-ATPase and phospholamban in the failing and nonfailing heart Cardiovasc Res, January 1, 2000; 45(1): 245 - 252. [Full Text] [PDF] |
||||
![]() |
F. del Monte, S. E. Harding, U. Schmidt, T. Matsui, Z. B. Kang, G. W. Dec, J. K. Gwathmey, A. Rosenzweig, and R. J. Hajjar Restoration of Contractile Function in Isolated Cardiomyocytes From Failing Human Hearts by Gene Transfer of SERCA2a Circulation, December 7, 1999; 100(23): 2308 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sumbilla, M. Cavagna, L. Zhong, H. Ma, D. Lewis, I. Farrance, and G. Inesi Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2381 - H2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt, R. J. Hajjar, C. S. Kim, D. Lebeche, A. A. Doye, and J. K. Gwathmey Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H474 - H480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske, L. S. Maier, D. M. Bers, and G. Hasenfuss Ca2+ Handling and Sarcoplasmic Reticulum Ca2+ Content in Isolated Failing and Nonfailing Human Myocardium Circ. Res., July 9, 1999; 85(1): 38 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Baker, K. Hashimoto, I. L. Grupp, Y. Ji, T. Reed, E. Loukianov, G. Grupp, A. Bhagwhat, B. Hoit, R. Walsh, et al. Targeted Overexpression of the Sarcoplasmic Reticulum Ca2+-ATPase Increases Cardiac Contractility in Transgenic Mouse Hearts Circ. Res., December 14, 1998; 83(12): 1205 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. B. SIMMERMAN and L. R. JONES Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function Physiol Rev, October 1, 1998; 78(4): 921 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hajjar, U. Schmidt, T. Matsui, J. L. Guerrero, K.-H. Lee, J. K. Gwathmey, G. W. Dec, M. J. Semigran, and A. Rosenzweig Modulation of ventricular function through gene transfer in vivo PNAS, April 28, 1998; 95(9): 5251 - 5256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meyer and W. H Dillmann Sarcoplasmic reticulum Ca2+-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice Cardiovasc Res, February 1, 1998; 37(2): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. DAVIA, R. J. HAJJAR, C. M. N. TERRACCIANO, N. S. KENT, H. K. RANU, P. O'GARA, A. ROSENZWEIG, and S. E. HARDING Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus Physiol Genomics, August 31, 1999; 1(2): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |